The use of herbs during pregnancy is on the rise today, but some of these plants can not only cause side effects in the mother and fetus but also have drug interactions. This systematic survey and meta-analysis reading were administered to define the outbreak of herbs used by women during pregnancy. The present work was performed using the meta-analysis method from March 2000 to February 2019. The search process was carried out in Iranian databases such as SID, Regional Information Center for Science and Technology (RICST), Mag-Iran, IranDoc, Barakat Knowledge Network System, Iranian National Library and international databases such as PubMed / Medline, Cochrane Library, Scopus, Science Direct, Web of Sciences, Embase, EBSCO, and Google Scholar. keywords including medicinal herbs, Medicinal plant, Plant, Extract, Women, and pregnancy. The heterogeneity of investigations was scrutinized using the I2 index. Analysis was carried out using Comprehensive Meta-Analysis software. A total of 73 articles were contained in the meta-analysis process. Based on the results, the general outbreak of medicinal herbs use during pregnancy was 32.4% (95% CI: 28.2%-36.8%). The results of meta-regression showed that increasing in sample size leads to decreased overall prevalence of herbal medicine consumption during pregnancy and increasing in the year of research leads to increased overall prevalence of herbal drug use during pregnancy, which both were statistically significant (P <0.05).The prevalence of medicinal herbs consumption during pregnancy is relatively high. پرونده مقاله

About 15% of patients with diabetes develop a Diabetic foot ulcer (DFU). It is an open sore or wound commonly located on the bottom of the foot.ANGIPARS™ is an Iranian-produced herbal remedy based on the extract of Melilotus officinalis. The aim of this study was to make a systematic review focused on determination of the effect of ANGIPARS™ on wound healing in patients with diabetes. The study was conducted in accordance with the PRISMA guidelines. Articles included in the review cover the period from the discovery of ANGIPARS™ to August 18, 2018. The data were analyzed using a descriptive method of Excel 2007 Software.Five articles with total number of 171 patients were included in the systematic review (SR) phase. In three articles, the methods were based on mm2 units and in the two others on cm2 units. Patients' follow-up varied from 4 weeks to 6 months after the intervention. In all patients, ANGIPARS™ responds well to the DFU disease. Due to the positive effect of the herbal drug, it is recommended to administer it for wound healing in patients with diabetes. پرونده مقاله